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A B S T R A C T
Childhood trauma (CT) is a risk factor for schizophrenia spectrum disorders (SSDs), and cognitive impairment is
a core feature and a vulnerability marker of SSDs. Studies of the relationship between CT and cognitive im-
pairment in SSDs are inconclusive. In addition, few studies have examined differential effects of CT subtypes, e.g.
physical, sexual or emotional abuse/neglect, on cognitive functioning. The present study therefore aimed to
examine the effects of CT and CT subtypes on cognitive impairment in SSD. Participants (n=78) with SSDs
completed a comprehensive neuropsychological test battery and the Childhood Trauma Questionnaire Short-
Form (CTQ-SF). We compared global cognitive performance as well as scores in seven subdomains (verbal
abilities, visuospatial abilities, learning, memory, attention/working memory, executive abilities and processing
speed) between participants reporting no CT and those reporting CT experiences using independent samples t-
tests as well as linear regression analyses to control for possible confounders. CT subtype physical neglect was
associated with attention and working memory after controlling for positive and negative psychosis symptoms,
years of education, antipsychotics, gender and age, and adjustment of multiple testing. Our results indicate that
the observed heterogeneity in cognitive impairment in SSDs, especially attention/working memory abilities,
may in part be associated with childhood physical neglect.
Cognitive impairment is both a core feature of schizophrenia spec-
trum disorders (SSDs; Carrion et al., 2015), a vulnerability marker, and
closely related to poor functional outcome and disability in SSDs (Kahn
and Keefe, 2013). However, there is great variation in reported cogni-
tive impairments in SSDs, and factors underlying this heterogeneity in
cognitive functioning remain poorly understood. Risk factors influen-
cing the development of SSDs may also potentially affect cognitive
functioning directly or indirectly, such as illicit substance use which is a
risk factor for psychosis, and has been found to influence cognitive
vulnerability for psychosis (Løberg et al., 2014).
Childhood trauma (CT), e.g. physical, sexual, emotional abuse and
physical and emotional neglect (Bernstein et al., 2003) is another risk
factor for SSDs (Mørkved et al., 2017) which may be associated with
cognitive impairment. The association between CT and SSDs is evident
across study designs and populations, and CT has been found to in-
crease the risk of psychosis with an odds ratio of 2.8 (Varese et al.,
2012). CT have been shown to have a detrimental effect on brain de-
velopment and cognitive functioning in non-psychotic individuals, at-
tributed to disrupted neurodevelopment and stress-regulating brain
systems (Pechtel and Pizzagalli, 2011). Understanding the relationship
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between CT and cognition in SSDs may thus aid both its etiological
understanding as well as treatment models for psychosis.
A handful of studies have found negative effects of CT on cognition
in SSD patients. Shannon et al. (2011) found that CT in SSD predicted
greater impairments in working memory and episodic memory as
compared to SSD with no history of CT. Quide et al. (2016) reported a
negative association between CT and working memory performance in
individuals with SSDs. However, some studies have failed to find an
association between CT and cognitive impairment in SSDs (e.g. van Os
et al., 2017). One study also indicated a positive effect of CT and cog-
nitive abilities in SSDs (Ruby et al., 2017).
One possible explanation for the observed variance of cognitive
impairment in SSDs might be differential effects of various types of CT
(Schalinski et al., 2016). Li et al. (2017) reported negative effects of
physical abuse, neglect and sexual abuse on language and attention.
Ucok et al. (2015) found physical CT to have a negative impact on
cognitive function in individuals at ultra-high risk of psychosis.
In addition, the mixed findings on CT and cognitive impairment in
SSDs could be attributed to discrepancies in the measurement of CT and
the use of non-validated self-report questionnaires. The Childhood
Trauma Questionnaire Short-Form (CTQ-SF; Bernstein et al., 1997)
used in the present study is described as a reliable measure of CT in
SSDs (Fisher et al., 2011). Finally, sample differences between studies
may also have contributed to the equivocal findings. For example, an-
tipsychotic drug use has been found to improve cognition in SSDs
(Johnsen et al., 2013).
In sum, findings on the relation between CT and cognitive impair-
ment in SSDs are inconclusive, and few studies to date have examined
whether CT subtypes might differentially affect cognitive functioning in
SSDs. The aim of the present study is therefore to investigate possible
effects of CT and CT subtypes on global cognitive performance and
specific cognitive domains in a clinically representative sample of pa-
tients with SSDs.
1. Methods and material
The present study is based on cross-sectional data from the Bergen
Psychosis project 2 (BP2), Haukeland University Hospital, Bergen,
Norway. The BP2 is an independently funded multi-site prospective
study including a randomized, rater-blind, head-to-head comparison of
amisulpride, aripiprazole, and olanzapine, approved by the Regional
Committee for Medical Research Ethics (2010–3387) and registered as
a clinical trial 10/03/2011 (www.clinicaltrials.gov: NCT01446328).
Inclusion/exclusion criteria for the BP2 have been described elsewhere
(Mørkved et al., 2018). The current sample consisted of 78 patients
with SSDs, 49 (63.6%) male, mean age 29.8 years (SD=12.4 years;
Table 1).
Participants were recruited at the Medical University in Innsbruck,
Innsbruck, Austria (n=10); Stavanger University Hospital, Stavanger,
Norway (n=8); and Haukeland University Hospital, Bergen, Norway
(n=60), and gave informed consent to participate.
Participants were required to meet diagnostic criteria for SSDs in the
range F20–29 of the ICD-10 (WHO, 1992): F20 Schizophrenia (n=44),
F21 Schizotypal disorder (n=2), F22 Persistent delusional disorder
(n=7), F23 Acute and transient psychotic disorders (n=11), F25
Schizoaffective disorder (n=5), or F29 Unspecified nonorganic psy-
chosis (n=9), as determined by the Structural Clinical Interview for
Axis I Disorders (SCID; Spitzer et al., 1992), be> 18 years of age, be
able to read, understand and speak the native language, and score≥ 4
on at least one of the following items on the Positive and Negative
Syndrome Scale (PANSS; Kay et al., 1987): Delusions (P1), hallucina-
tory behavior (P3), grandiosity (P5), suspiciousness/persecution (P6) or
unusual thought content (G9). Exclusion criteria were organic psychosis
or psychosis due to substance use.
2. Measurement
2.1. Childhood trauma
The CTQ-SF is a 28-item self-report questionnaire screening for five
subtypes of childhood trauma: childhood sexual, physical and emo-
tional abuse, and physical and emotional neglect (Bernstein et al.,
2003). Each subscale consists of five items scored on a five-point Likert
scale ranging from 1 (never true) to 5 (very often true), summarized into
an overall CTQ-SF sum score ranging from 25 to 125. Three items make
up the Minimization-denial subscale. The CTQ-SF has shown good in-
ternal consistency, test-retest reliability, and excellent internal relia-
bility, as well as good sensitivity and specificity (Dovran et al., 2013).
For the present study, the overall reliability estimate for the CTQ-SF
was high: Cronbach's α=0.91. Subscale Cronbach's α were: Emotional
abuse= 0.88, physical abuse= 0.80, sexual abuse=0.91, emotional
neglect= 0.92, and physical neglect= 0.60.
2.2. Cognitive assessment
Trained research nurses performed the cognitive assessments: a
three-hour comprehensive test battery. The following seven domains of
cognition were assessed: 1) verbal abilities; 2) visuospatial abilities; 3)
verbal learning; 4) memory (long-term memory and recognition); 5)
attention/working memory; 6) executive abilities and 7) processing
speed.
Verbal abilities were assessed by the Wechsler Adult Intelligence
Scale III (WAIS III; Wechsler, 1997) subtests vocabulary and similarities
subtests, and the Delis-Kaplan Executive Function System (D-KEFS)
verbal fluency test (Delis et al., 2001). Visuospatial abilities were as-
sessed by the WAIS III subtests block design and digit symbol-coding, as
well as the Rey-Osterrieth Complex Figure Test (Shin et al., 2006).
Learning was assessed by the California verbal learning test (CVLT;
Delis et al., 1987) i.e. trials 1–5, and the digit span subtest of the WAIS
III. Memory was assessed by the CVLT (subtests short delay free and
cued recall, long delay free and cued recall, and delayed recognition)
and Rey-Osterrieth Complex Figure Test (Shin et al., 2006). Attention
and working memory were assessed by the Digit vigilance test (Lewis
and Rennick, 1979), the CALCAP Continuous Performance Test subtests
sequential reaction time and choice reaction time (Miller, 1990), Trail
Making Test (TMB; Reitan, 1986), the WAIS III subtests digit span and
letter-number sequencing, and the Wechsler Memory Scale (Wechsler,
1997). Executive abilities were measured using the Wisconsin Card
Sorting test (Heaton, 1981) and the Stroop test (Stroop, 1935). Pro-
cessing speed was measured using the TMA (Reitan, 1986), the digit
symbol-coding subtest of the WAIS III, the Grooved Pegboard Test
(Bryden and Roy, 2005), and the CALCAP subtest simple reaction time
(Conners, 2002).
The study included well-validated and reliable cognitive measures
commonly used in studies of cognitive functioning in individuals with
SSDs: The Wechsler Memory Scale (Wechsler, 1997) was found to be a
reliable measure of memory deficits in schizophrenia (Gold et al.,
1992). The WAIS III is described as having good psychometric prop-
erties (Silva, 2008). The Delis Kaplan Executive Function System (D-
KEFS) (Delis et al., 2001) was found to have good psychometric prop-
erties (Shunk et al., 2006), as did the TMT Part A and B (Bowie and
Harvey, 2006; Delis et al., 2001), the Grooved Pegboard Test (Erdodi
et al., 2018) and the Rey-Osterrieth Complex Figure Test (Shin et al.,
2006). The CVLT (Delis et al., 1987) is described as reliable and valid
(Woods et al., 2006). The CALCAP Continuous performance test was
found to possess adequate psychometric properties (Miller, 1990). Kopp
et al. (2019) report promising reliability data for the Wisconsin Card
Sorting test (Heaton, 1981).
Raw scores from cognitive tests were converted to standardized t-
scores based on the best available norms (corrected for age, but not for
gender and education). Cognitive domain t-scores were calculated as
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the mean t-score across tests for each domain. A global cognitive per-
formance t-score was calculated by averaging the t-scores from every
test.
2.3. Other measurements
The use of antipsychotic drugs at the time of neurocognitive testing
was converted to Defined Daily Doses (DDD) as given by the World
Health Organization Collaborating Centre for Drug Statistics
Methodology at the Norwegian Institute of Public Health (www.whocc.
no). The DDD is the assumed average maintenance dose per day for a
drug used for its main indication in adults. Adherence with medication
was assessed by means of serum level measurements of antipsychotic
drugs.
2.4. Procedure
Patients included in BP 2 were assessed at baseline, week 1, 3, 6, 12,
26, 39 and 52. The CTQ-SF was administered at the 6-weeks. The
PANSS was measured at week 1, and the cognitive test battery at the
12-week follow-up.
2.5. Statistical analyses
All analyses were carried out using STATA. Measures are presented
as means (M) and standard deviations (SD), or as number (n) and
percentages (%). A p-level of < .05 was considered statistically sig-
nificant, except for in the regression analyses where we corrected for
multiple testing by means of a Bonferroni adjustment (0.05/
40= p < .00125). Missing data were handled through imputation
based on expectation maximation, and the amount of missing data in
Table 1
Mean (SD) clinical and demographic characteristics by CT/no CT group.
No CT (n=37) CT (n=41) Total (n=78) t/χ2 p-Value
Age 29.46 (11.97) 30.20 (12.87) 29.84 (12.37) −0.26 0.795
Gender
Male 28 (57.14%) 21 (42.86%) 49 (62.80%) 4.98 0.026*
Female 9 (31.03%) 20 (68.97%) 29 (37.20%)
Duration of illness (n=70) 5.99 (10.71) 5.30 (5.99) 5.63 (8.55) 0.33 0.737
Duration of untreated psychosis (n=58) 26 (36.87) 83.06 (132.35) 55.52 (101.90) −2.20 0.032
Antipsychotics DDD 1.18 (0.51) 1.13 (0.80) 1.30 (0.75) 0.34 0.736
Years of education 13 (2.79) 11.88 (2.67) 12.41 (2.76) 1.82 0.073
Education
Primary 14 (42.42%) 19 (57.58%) 33 (42.3%) 0.73 0.392
Further 23 (52.27%) 21 (47.73%) 44 (57.14%)
Civil status
Single 30 (49.18%) 31 (50.82%) 61 (91%) 0.67 0.414
Married/divorced 4 (66.67%) 2 (33.33%) 6 (9%)
Living situation
Independently 20 (47.62%) 22 (52.38%) 42 (54.55%) 1.09 0.578
Supported housing/institution 16 (42.11%) 18 (47.37%) 34 (44.16%)
No residence 1 (100%) 0 (0%) 1 (1.30%)
PANSS baseline (n=77)
Positive symptoms 18.54 (5.59) 21.38 (5.30) 20.01 (5.59) −2.28 0.025*
Negative symptoms 15.84 (6.38) 19.05 (6.33) 17.51 (6.51) −2.22 0.029*
General psychopathology scale 36.41 (11.34) 39.40 (7.66) 37.96 (9.66) −1.37 0.175
Total 70.78 (20.89) 79.83 (14.79) 75.48 (18.43) −2.21 0.029*
DUDIT (n=54) 12.73 (12.57) 9.34 (11.92) 10.97 (12.24) 1.02 0.313
AUDIT (n=68) 9.10 (6.46) 8.19 (6.43) 8.63 (6.41) 0.59 0.559
CTQ-SF
Emotional abuse 6.46 (1.94) 12.85 (5.24) 9.82 (5.13) −7.00 0.001*
Physical abuse 5.22 (0.53) 7.24 (3.63) 6.28 (2.83) −3.37 0.001*
Sexual abuse 5.05 (0.33) 7.34 (4.25) 6.28 (3.28) −3.26 0.001*
Emotional neglect 7.73 (2.62) 14.95 (5.58) 11.52 (5.71) −7.18 0.001*
Physical neglect 6.24 (1.46) 9.48 (3.67) 9.95 (3.26) −5.03 0.001*
Sum 30.70 (3.99) 51.88 (14.21) 41.83 (15.02) −8.75 0.001*
Cognitive domains
Verbal abilities (n=76) 49.35 (9.54) 45.64 (9.13) 47.39 (9.45) 1.73 0.087
Visuospatial abilities 46.73 (10.18) 44.39 (9.78) 45.50 (9.97) 1.03 0.306
Learning 43.63 (7.35) 42.21 (7.50) 42.88 (7.42) 0.85 0.400
Memory 46.03 (6.99) 43.15 (8.84) 44.52 (8.10) 1.58 0.116
Attention/working memory 44.20 (6.47) 42.39 (8.84) 43.25 (7.81) 1.02 0.309
Executive abilities (n=75) 48.97 (10.99) 45.29 (12.09) 47.05 (11.65) 1.38 0.173
Processing speed 43.59 (8.05) 40.75 (10.03) 42.10 (9.19) 1.37 0.175
Global cognitive performance 46.20 (6.39) 43.45 (7.59) 44.76 (7.13) 1.69 0.095
Note. N= 78 if not stated otherwise. Continuous variables analyzed using independent samples t-test, and categorical variables analyzed using χ2. Duration of
untreated psychosis in weeks, and duration of illness in years. DDD=defined daily dose, PANSS=The Positive and Negative Syndrome Scale, CTQ-SF=Childhood
Trauma Questionnaire Short Form, AUDIT=Alcohol Use Disorder Identification Test, DUDIT=Drug Use Disorder Identification Test. * significant at p < .05.
Verbal abilities: Wechsler Adult Intelligence Scale III (WAIS III; Wechsler, 1997) subtests vocabulary and similarities subtests, and the D-KEFS verbal fluency test
(Delis et al., 2001). Visuospatial abilities: Block design and digit symbol-coding subtests of WAIS III, as well as the Rey-Osterrieth Complex Figure Test (Shin et al.,
2006). Learning: California verbal learning test (CVLT; Delis et al., 1987) trials 1–5, and the digit span subtest of the WAIS III. Memory: CVLT (subtests short delay
free and cued recall, long delay free and cued recall, and delayed recognition) and Rey-Osterrieth Complex Figure Test (Shin et al., 2006). Attention/working
memory: Digit vigilance test (Lewis and Rennick, 1979), the CalCAP Continuous performance test subtests sequential reaction time and choice reaction time
(Conners, 2002), Trail Making Test (Part B) (Reitan, 1986), the WAIS III subtests digit span and letter-number sequencing, and the Wechsler Memory Scale (Wechsler,
1997). Executive abilities: Wisconsin Card Sorting test (Heaton, 1981) and the Stroop test (Stroop, 1935). Processing speed: Trail Making Test (Part A) (Reitan, 1986),
the digit symbol-coding subtest of the WAIS III, the Grooved Pegboard Test (Bryden and Roy, 2005), and the CalCAP subtest simple reaction time (Conners, 2002).
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the CTQ-SF scale was 0.73%.
CTQ-SF scores were categorized into none, low, moderate and se-
vere abuse or neglect, based on threshold scores in the CTQ-SF manual.
A dichotomous variable was created, grouping none and low levels of
CT (meaning CT absent) on the one hand, and moderate and severe
levels (CT present) on the other (Bernstein and Fink, 1998). The sample
was divided into two groups: Participants reporting CT (n=41), and
participants with no CT experiences (n=37). The relation between
demographic variables and CT/no CT-groups was investigated using
independent sample t-tests, non-parametric Mann-Whitney U test, or χ2
tests. Significant results in these tests determined the inclusion of that
variable in the regression models to control for confounders. Anti-
psychotics was included based on previous research showing effect on
cognition in SSDs receiving antipsychotic treatment (Johnsen et al.,
2013).
For the linear regression analyses, CTQ-SF subscale scores (5–25)
were used as predictors for the cognitive performance scores. The first
analyses used CTQ-SF subscales as predictors for the cognitive domains.
Then, we included gender, PANSS positive and negative symptom
scales, and antipsychotic medication (DDD) as confounders. Due to
multicollinearity, the PANSS total score was omitted from the analyses.
In the last model, we controlled for years of education if this was not
already corrected for in the test scoring norms. All scoring norms were
corrected for age.
The goodness of fit as measured by adjusted R2 (R2a) is assessed as
small if ≤0.09, moderate between 0.1 and 0.3 and large effect if ≥0.3
(Mehmetoglu and Jakobsen, 2017). We visually inspected frequency
distributions of variables for normality. All regression models were
tested for, and adhered to, the assumptions underlying linear multiple
regression.
3. Results
3.1. Demographic and clinical data
When examining the CTQ-SF, we found that 21 of 78 (26.9%)
patients with SSDs reported emotional abuse, 8 of 78 (10.3%) reported
physical abuse, 12 of 78 (15.4%) reported sexual abuse, 23 of 78
(29.5%) reported emotional neglect and 20 of 78 (25.6%) reported
physical neglect (according to the cut-off of moderate to severe level of
abuse and neglect). Further, 37 (47.4%) patients reported no CT, and 41
(52.6%) patients reported 1–5 CT.
We tested for gender differences between CT/no CT groups, and
found that the majority of male participants reported no CT, whereas
the majority of the female participants reported CT experiences. This
difference was statistically significant (Table 1). We also found that the
CT group reported significantly higher levels of positive and negative
psychosis symptoms compared to the no CT group (Table 1). There
were no other significant effects of demographic and clinical data on
CT/no CT groups. Further, serum levels generally corresponded well
with the antipsychotic drug doses (DDD), indicating satisfactory ad-
herence with medication.
Mean (SD) median, skewness and kurtosis was the following for
cognitive domains: Global cognitive performance 44.76 (7.13) 45.26,
−0.24 and 2.55; verbal abilities 47.39 (9.45) 46.12, 0.41 and 2.76;
visuospatial abilities 45.50 (9.98) 45.88, −0.30 and 2.40; learning
42.89 (7.41) 41.88, −0.02 and 3.51; memory 44.52 (8.10) 43.84,
−0.77 and 4.25; attention/working 43.25 (7.81) 42.89, −0.03 and
2.77; executive abilities 47.05 (11.65) 47.5, −0.51 and 3.23; proces-
sing speed 42.10 (9.19) 43.25, −0.34 and 3.13. The values were as-
sessed as satisfactory.
3.2. Comparison of cognitive performance in SSDs by CT/no CT groups
We compared cognitive performance in two groups of SSDs patients;
one group with no CT, compared to those reporting CT experiences
There were no statistically significant differences in global cognitive
performance between CT/no CT groups (p= .095), nor in verbal abil-
ities (p= .087), visuospatial abilities (p= .306), learning (p= .400),
memory (p= .116), attention/working memory (p= .309), executive













Verbal abilities Visuospatial abilities Learning Memory Attention/working memoryExecutive abilities Processing speedGlobal cognitive performance
 NO CT
 CT
Fig. 1. Cognitive performance by cognitive domain grouped by CT.
Note. N=78, except verbal abilities (n=76) and executive abilities (n=75). CT=moderate to severe childhood trauma. Bonferroni adjusted p-level of .00125. No
significant results. Verbal abilities: Wechsler Adult Intelligence Scale III (WAIS III; Wechsler, 1997) subtests vocabulary and similarities subtests, and the D-KEFS
verbal fluency test (Delis et al., 2001). Visuospatial abilities: Block design and digit symbol-coding subtests of WAIS III, as well as the Rey-Osterrieth Complex Figure
Test (Shin et al., 2006). Learning: California verbal learning test (CVLT; Delis et al., 1987) trials 1–5, and the digit span subtest of the WAIS III. Memory: CVLT
(subtests short delay free and cued recall, long delay free and cued recall, and delayed recognition) and Rey-Osterrieth Complex Figure Test (Shin et al., 2006).
Attention/working memory: Digit vigilance test (Lewis and Rennick, 1979), the CalCAP Continuous performance test subtests sequential reaction time and choice
reaction time (Conners, 2002), Trail Making Test (Part B) (Reitan, 1986), the WAIS III subtests digit span and letter-number sequencing, and the Wechsler Memory
Scale (Wechsler, 1997). Executive abilities: Wisconsin Card Sorting test (Heaton, 1981) and the Stroop test (Stroop, 1935). Processing speed: Trail Making Test (Part
A) (Reitan, 1986), the digit symbol-coding subtest of the WAIS III, the Grooved Pegboard Test (Bryden and Roy, 2005), and the CalCAP subtest simple reaction time
(Conners, 2002).
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3.3. The association of CT subtypes on cognitive performance
In the first linear regression models, we tested for the effect of CT
subtypes on cognitive performance in SSDs. The analyses showed sta-
tistically significant effects for the regression models (CT subtypes as
predictors) on global cognitive performance, F(5, 69)= 3.14, p= .013,
adjusted R2 (R2a)= 0.13, visuospatial abilities, F(5, 72)= 2.99,
p= .016, R2a = 0.11, learning, F(5, 72)= 2.76, p= .024, R2a = 0.10,
memory, F(5, 72)= 3.32, p= .009, R2a = 0.13, attention and working
memory, F(5, 72)= 4.90, p < .001, R2a = 0.20, and processing speed, F
(5, 72)= 2.61, p= .031, R2a = 0.10. Goodness of fit for the models was
small to moderate. No significant effects were found for the CT subtypes
and verbal abilities (p= .131) and executive functioning (p= .419).
After correcting for multiple comparisons (Bonferroni adjustment
0.05/40= p < .00125), the results indicated that the association be-
tween the predictors and cognitive impairment in SSDs is mainly driven
by physical neglect in predicting impairment in global cognitive per-
formance (p < .001), visuospatial abilities (p < .001), attention/
working memory (p < .001) and memory (p < .001; Table 2).
3.4. The association of CT subtypes on cognitive performance controlling for
gender and psychosis symptoms
We tested for the effect of CT subtypes on cognitive performance in
SSDs and controlled for gender, positive and negative psychosis
symptoms, and antipsychotic medication.
The analyses showed statistically significant effects for the regres-
sion models based on the predictors (CT subtypes, gender, psychosis
symptoms, antipsychotics) on global cognitive performance, F(9,
62)= 2.95, p= .005, R2a = 0.19, visuospatial abilities, F(9, 65)= 2.67,
p= .010, R2a = 0.16, learning, F(9, 65)= 2.65, p= .011, R2a = 0.16,
memory, F(9, 65)= 3.75, p < .001, R2a = 0.25, and attention and
working memory, F(9, 65)= 3.60, p= .001, R2a = 0.24, and processing
speed, F(9, 65)= 3.57, p < .001, R2a = 0.24. Goodness of fit for the
models (R2a) was assessed as small to moderate. No significant effects
were found for the CT subtypes and executive functioning (p= .636)
and verbal abilities (p= .122).
After correcting for multiple comparisons (Bonferroni adjustment
0.05/40= p < .00125), the results indicate that the association be-
tween the predictors and cognitive impairment in SSDs is mainly driven
by the CT subtype physical neglect (see Table 3). Increase in reported
physical neglect predicted more impairment in attention/working
memory abilities (p < .001; Table 3).
Lastly, we performed the analyses including education as a pre-
dictor for the cognitive domains. The analyses showed statistically
significant effects for the regression models based on the predictors (CT
subtypes, gender, psychosis symptoms, antipsychotics and education)
on global cognitive performance, F(10, 61)= 4.59, p < .001,
R2a = 0.33, verbal abilities, F(10, 62)= 3.42, p < .001, R2a = 0.25, vi-
suospatial abilities, F(10, 64)= 5.05, p < .001, R2a = 0.35, learning, F
(10, 64)= 4.34, p < .001, R2a = 0.31, memory, F(10, 64)= 5.85,
p < .001, R2a = 0.40, attention and working memory, F(9, 65)= 3.60,
p < .001, R2a = 0.24, and processing speed, F(9, 65)= 3.57, p < .001,
R2a = 0.23. Goodness of fit for the models (R2a) was assessed as moderate
to large. No significant effects were found for the CT subtypes and ex-
ecutive functioning (p= .722).
After correcting for multiple comparisons (Bonferroni adjustment
0.05/40= p < .00125), the results indicate that the association be-
tween the predictors and cognitive impairment in SSDs is mainly driven
by the CT subtype physical neglect (see Table 4). Increase in reported
physical neglect predicted more impairment in attention/working
memory abilities (p < .001; Table 4).
4. Discussion
Reported levels of childhood physical neglect in our sample of SSDs
predicted significant impairment in cognitive performance in attention/
working memory abilities after adjusting for multiple comparisons, and
controlling psychosis symptoms, antipsychotics, years of education, age
and gender. In contrast, we found no significant differences in cognitive
functioning between CT and no CT groups, nor between any other
subtype of CT and the studied cognitive domains. Our findings re-
garding physical neglect indicate that CT subtypes might differentially
influence cognitive abilities.
Half of our sample of patients with SSDs reported experiences of
moderate to severe CT. Of those reporting CT, the majority had ex-
perienced up to three subtypes of CT. This is in line with previous
studies on CT in SSDs (McGrath et al., 2017), and reports of co-occur-
rence of types of CT (Kessler et al., 2010). Our findings regarding as-
sociations between reports of CT and cognitive impairment, are in
agreement with previous reports (Quide et al., 2016; Shannon et al.,
2011). We did not find all types of CT to predict cognitive impairment
in our sample of SSDs. This may in part explain inconsistency in pre-
vious research (Dauvermann and Donohoe, 2019): While some studies
report associations between CT and cognitive impairment in SSDs (Aas
et al., 2014), others, e.g. Ruby et al. (2017), did not find early trauma to
Table 2













Emotional abuse −0.134 0.096 0.026 −0.143 0.088 −0.227 −0.222 −0.444
(−0.58) (0.30) (0.08) (−0.61) (0.35) (−0.98) (−0.57) (−1.53)
Physical abuse 0.007 −0.483 0.254 0.096 −0.146 0.065 0.747 0.280
(0.02) (−0.77) (0.43) (0.21) (−0.31) (0.15) (0.99) (0.50)
Sexual abuse 0.152 −0.0265 0.014 −0.084 0.233 0.021 −0.191 0.242
(0.48) (−0.06) (0.03) (−0.27) (0.69) (0.07) (−0.36) (0.62)
Emotional neglect 0.348 −0.0281 0.343 0.416⁎ 0.261 0.511⁎⁎ 0.334 0.444
(1.84) (−0.11) (1.35) (2.18) (1.28) (2.70) (1.05) (1.88)
Physical neglect −1.288⁎⁎⁎ −1.013⁎ −1.560⁎⁎⁎ −1.027⁎⁎ −1.243⁎⁎⁎ −1.342⁎⁎⁎ −1.182⁎ −1.142⁎⁎
(−4.12) (−2.21) (−3.72) (−3.27) (−3.70) (−4.31) (−2.13) (−2.92)
Constant 50.86 58.40 52.01 47.58 50.01 49.71 51.22 47.14
(20.21) (15.91) (15.40) (18.82) (18.50) (19.81) (11.57) (14.97)
N 75 76 78 78 78 78 75 78
Note. Numbers are regression coefficients, and t-statistics in parenthesis. Constant= The value of the dependent variable holding all predictors constant.
PANSS=The Positive and Negative Syndrome Scale. CTQ-SF=Childhood trauma questionnaire short-form. Unstandardized coefficients are reported due to the
independent variables being measured in the same metric.
⁎ p < .05.
⁎⁎ p < .01.
⁎⁎⁎ Bonferroni corrected p < .00125.
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predict cognitive impairment. Our findings indicate that CT subtype
physical neglect may in part explain these discrepancies.
Schalinski et al. (2016) suggested that some of the variance in
cognitive impairment in SSDs could be explained by subtype of CT, as
demonstrated by our findings that physical neglect is more closely as-
sociated with poorer cognitive performance. Our findings are in line
with reports such as Li et al. (2017), whom in a sample of patients with
SSDs found an association between physical neglect and impaired
Table 3












Emotional abuse 0.202 0.162 0.428 −0.0389 0.340 0.0355 0.223 0.147
(0.85) (0.46) (1.22) (−0.16) (1.27) (0.14) (0.49) (0.50)
Physical abuse −0.223 −0.772 −0.132 −0.239 −0.502 −0.286 0.615 −0.216
(−0.54) (−1.26) (−0.22) (−0.56) (−1.09) (−0.67) (0.77) (−0.43)
Sexual abuse −0.0505 0.00466 −0.0631 −0.0577 0.231 −0.0457 −0.402 −0.00674
(−0.17) (0.01) (−0.15) (−0.19) (0.71) (−0.15) (−0.71) (−0.02)
Emotional neglect 0.198 0.0567 0.184 0.437⁎ 0.239 0.427⁎ 0.0547 0.114
(1.02) (0.20) (0.65) (2.18) (1.10) (2.11) (0.15) (0.48)
Physical neglect −1.001⁎⁎ −0.797 −1.328⁎⁎ −0.730⁎ −0.994⁎⁎ −1.082⁎⁎⁎ −1.009 −0.947⁎⁎
(−3.31) (−1.79) (−3.15) (−2.44) (−3.07) (−3.59) (−1.74) (−2.69)
Gender 0.731 2.986 −0.426 1.734 0.145 0.749 −1.031 1.644
(0.45) (1.26) (−0.18) (1.05) (0.08) (0.45) (−0.33) (0.84)
PANSS positive 0.109 0.287 0.123 0.0617 −0.0399 0.0721 0.0610 0.145
(0.78) (1.38) (0.59) (0.42) (−0.25) (0.49) (0.23) (0.84)
PANSS negative −0.211 −0.405 −0.227 −0.319⁎ −0.410⁎⁎ −0.130 0.0151 −0.00123
(−1.49) (−1.94) (−1.14) (−2.26) (−2.69) (−0.91) (0.06) (−0.01)
Antipsychotics DDD −2.448⁎ −0.500 −3.435⁎ −1.594 −1.648 −2.825⁎ −2.438 −5.129⁎⁎⁎
(−2.34) (−0.32) (−2.22) (−1.46) (−1.39) (−2.56) (−1.21) (−3.98)
Constant 54.76 57.28 57.26 52.06 58.20 53.28 53.25 51.71
(15.74) (11.17) (11.72) (15.04) (15.52) (15.26) (7.98) (12.68)
N 72 73 75 75 75 75 72 75
Note. t-statistics in parenthesis. Constant=The value of the dependent variable holding all predictors constant. PANSS=The Positive and Negative Syndrome Scale.
CTQ-SF=Childhood trauma questionnaire short-form. DDD= the assumed average maintenance dose per day for a drug used for its main indication in adults.
Unstandardized coefficients are reported due to the independent variables being measured in the same metric.
⁎ p < .05.
⁎⁎ p < .01.
⁎⁎⁎ Bonferroni corrected p < .00125.
Table 4












Emotional abuse 0.192 0.147 0.432 −0.0360 0.344 0.0355 0.223 0.147
(0.88) (0.46) (1.40) (−0.16) (1.42) (0.14) (0.49) (0.50)
Physical abuse −0.310 −0.909 −0.312 −0.351 −0.631 −0.286 0.615 −0.216
(−0.82) (−1.64) (−0.59) (−0.91) (−1.52) (−0.67) (0.77) (−0.43)
Sexual abuse 0.158 0.323 0.301 0.171 0.493 −0.0457 −0.402 −0.00674
(0.57) (0.80) (0.79) (0.61) (1.65) (−0.15) (−0.71) (−0.02)
Emotional neglect 0.124 −0.0477 0.0592 0.359 0.149 0.427⁎ 0.0547 0.114
(0.70) (−0.18) (0.24) (1.95) (0.76) (2.11) (0.15) (0.48)
Physical neglect −0.769⁎⁎ −0.452 −0.994⁎ −0.520 −0.754⁎ −1.082⁎⁎⁎ −1.009 −0.947⁎⁎
(−2.72) (−1.10) (−2.62) (−1.87) (−2.54) (−3.59) (−1.74) (−2.69)
Gender 0.664 3.010 −0.523 1.673 0.0754 0.749 −1.031 1.644
(0.45) (1.41) (−0.25) (1.11) (0.05) (0.45) (−0.33) (0.84)
PANSS positive 0.0337 0.168 0.000714 −0.0151 −0.128 0.0721 0.0610 0.145
(0.26) (0.89) (0.00) (−0.11) (−0.89) (0.49) (0.23) (0.84)
PANSS negative −0.149 −0.317 −0.144 −0.267⁎ −0.350⁎ −0.130 0.0151 −0.00123
(−1.15) (−1.67) (−0.82) (−2.07) (−2.54) (−0.91) (0.06) (−0.01)
Antipsychotics DDD −2.081⁎ 0.0694 −2.739⁎ −1.156 −1.147 −2.825⁎ −2.438 −5.129⁎⁎⁎
(−2.17) (0.05) (−2.00) (−1.15) (−1.07) (−2.56) (−1.21) (−3.98)
Education 0.925⁎⁎⁎ 1.445⁎⁎⁎ 1.570⁎⁎⁎ 0.989⁎⁎⁎ 1.131⁎⁎⁎
(3.72) (3.99) (4.42) (3.81) (4.08)
Constant 41.57 36.90 35.47 38.34 42.50 53.28 53.25 51.71
(8.75) (5.36) (5.42) (8.01) (8.31) (15.26) (7.98) (12.68)
N 72 73 75 75 75 75 72 75
Note. t-statistics in parenthesis. Constant=The value of the dependent variable holding all predictors constant. PANSS=The Positive and Negative Syndrome Scale.
CTQ-SF=Childhood trauma questionnaire short-form. DDD= the assumed average maintenance dose per day for a drug used for its main indication in adults.
Unstandardized coefficients are reported due to the independent variables being measured in the same metric. Years of education is included in the regression models
only in domains that did not already have the correction in the cognitive test scoring norms.
⁎ p < .05.
⁎⁎ p < .01.
⁎⁎⁎ Bonferroni corrected p < .00125.
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attention and memory, Traditionally, research has mainly focused on
sexual and physical abuse (De Bellis et al., 2009). Although childhood
neglect is frequently reported, the neurocognitive effects of neglect are
understudied (De Bellis et al., 2009). As neglect entails an inability to
meet basic emotional and physical needs, including nutrition and
proper medical care during illness, and is related to other forms of
abuse, the adverse neurocognitive consequences could be more ex-
tensive than for other types of abuse (Wells et al., 2019). Molina et al.
(2018) found physical and emotional neglect to be negatively related to
cognitive measures and report preliminary evidence for a role of early
neglect in disrupted development of prefrontal cortex (PFC) con-
nectivity and disturbed myelination regulation in SSDs. Early neglect at
3 years was found to predict hair cortisol concentration (HCC) in a
transdiagnostic group (Schalinski et al., 2019b). HCC indicates cumu-
lative cortisol levels associated with long term stress-reactions, in-
dicating altered HPA-axis biology following inadequate care (Schalinski
et al., 2019b). Thus, the absence of a reliable caregiver could be asso-
ciated with negative impact on the developing brain (De Bellis et al.,
2009) due to disrupting normative brain development during sensitive
periods (Schalinski et al., 2019a), possibly affecting cognitive func-
tioning in adulthood. Childhood neglect could thus be characterized as
an impoverished parent-child relationship, which may in turn be a
marker of an inherited cognitive vulnerability compounded by a gene-
environment interaction, thus increasing psychopathology (Schalinski
et al., 2019a). Maltreated and neglected children are also more likely to
have parents who were themselves maltreated or traumatized, in-
dicating intergenerational transmission involving maltreatment and
neglect, deficient parenting skills, family stressors and genetic and
epigenetic risk (Teicher and Samson, 2013).
When interpreting our findings, our limited sample size should be
taken into account, as this boosts the risk of a Type II error. We did not
use a control group in the present study, limiting knowledge on how
levels of CT and cognitive performance compare to participants without
SSDs. We were unable to control for cannabis use, socio-economic
status or parental cognitive functioning, known to influence cognitive
impairment in SSDs (Wells et al., 2019; Løberg et al., 2014). CT is
measured retrospectively and by self-report, which might be associated
to problems with validity and reliability. However, retrospective mea-
surement of CT in SSDs is indicated to be valid and reliable (Fisher
et al., 2011), albeit afflicted with common problems of retrospective
self-reported methods of measuring CT (Baldwin et al., 2019).
Strengths of the study are the large clinical cognitive test-battery
used, and the CTQ-SF is a well validated measure of CT, which allowed
us to better differentiate between subtypes than much of the previous
literature using other measures. Future research could benefit from a
longitudinal design, with CT measured more close in time to the trauma
and with additional measures to self-report.
Funding
The study was publicly funded by the Research Council of Norway
(#213727) and the Western Norway Regional Health Authority
(#911679, #911820) to EJ; by the Northern Norway Regional Health
Authority (#PFP1300-16) to NM; as well as by the participating hos-
pitals and universities. The study was not supported or funded by the
pharmaceutical industry, nor did other funding agencies support data
collection, interpretation, analyses or writing the report.
CRediT authorship contribution statement
N. Mørkved:Writing - original draft, Writing - review & editing,
Investigation, Visualization, Conceptualization.E. Johnsen:Data
curation, Writing - original draft, Writing - review & editing,
Conceptualization.R.A. Kroken:Data curation, Writing - original
draft, Writing - review & editing, Conceptualization.R.
Gjestad:Writing - original draft, Writing - review & editing, Formal
analysis, Conceptualization.D. Winje:Writing - original draft,
Writing - review & editing, Conceptualization.J. Thimm:Writing -
original draft, Writing - review & editing, Conceptualization.F.
Fathian:Data curation, Writing - original draft, Writing - review &
editing, Conceptualization.M. Rettenbacher:Data curation, Writing
- original draft, Writing - review & editing, Conceptualization.L.G.
Anda:Data curation, Writing - original draft, Writing - review &
editing, Conceptualization.E.M. Løberg:Formal analysis, Data
curation, Writing - original draft, Writing - review & editing,
Conceptualization.
Declaration of competing interest
The authors declare that they have no conflict of interest.
Acknowledgement
The authors would like to thank all participants and collaborators
for participation in the project.
References
Aas, M., Dazzan, P., Mondelli, V., Melle, I., Murray, R.M., Pariante, C.M., 2014. A sys-
tematic review of cognitive function in first-episode psychosis, including a discussion
on childhood trauma, stress, and inflammation. Front Psychiatry 4, 182.
Baldwin, J.R., Reuben, A., Newbury, J.B., Danese, A., 2019. Agreement between pro-
spective and retrospective measures of childhood maltreatment: a systematic review
and meta-analysis. Jama Psychiat 76, 584–593.
Bernstein, D.P., Fink, L., 1998. Childhood Trauma Questionnaire. A Retrospective Self-
report Manual. The Psychological Corporation, Harcourt Brace & Company, San
Antonio, USA.
Bernstein, D.P., Ahluvalia, T., Pogge, D., Handelsman, L., 1997. Validity of the Childhood
Trauma Questionnaire in an adolescent psychiatric population. J. Am. Acad. Child
Adolesc. Psychiatry 36, 340–348.
Bernstein, D.P., Stein, J.A., Newcomb, M.D., Walker, E., Pogge, D., Ahluvalia, T., Stokes,
J., Handelsman, L., Medrano, M., Desmond, D., Zule, W., 2003. Development and
validation of a brief screening version of the Childhood Trauma Questionnaire. Child
Abuse Negl. 27, 169–190.
Bowie, C.R., Harvey, P.D., 2006. Administration and interpretation of the Trail Making
Test. Nat. Protoc. 1, 2277–2281.
Bryden, P.J., Roy, E.A., 2005. A new method of administering the Grooved Pegboard Test:
performance as a function of handedness and sex. Brain Cogn. 58, 258–268.
Carrion, R.E., McLaughlin, D., Auther, A.M., Olsen, R., Correll, C.U., Cornblatt, B.A.,
2015. The impact of psychosis on the course of cognition: a prospective, nested case-
control study in individuals at clinical high-risk for psychosis. Psychol. Med. 45,
3341–3354.
Conners, C.K., 2002. Conners' Continuous Performance Test. Multi-health system,
Toronto, Canada.
Dauvermann, M.R., Donohoe, G., 2019. The role of childhood trauma in cognitive per-
formance in schizophrenia and bipolar disorder - a systematic review. Schizophr Res
Cogn 16, 1–11.
De Bellis, M.D., Hooper, S.R., Spratt, E.G., Woolley, D.P., 2009. Neuropsychological
findings in childhood neglect and their relationships to pediatric PTSD. J. Int.
Neuropsychol. Soc. 15, 868–878.
Delis, D.C., Kramer, J.H., Kaplan, E., Thompkins, B.A.O., 1987. CVLT: California Verbal
Learning Test-Adult Version: Manual. Psychological Corporation San Antonio.
Delis, D.C., Kaplan, E., Kramer, J.H., 2001. Delis-Kaplan Executive Function System® (D-
KEFS®). Examiner's Manual: Flexibility of Thinking, Concept Formation, Problem
Solving, Planning, Creativity, Impluse Control, Inhibition. Pearson.
Dovran, A., Winje, D., Overland, S.N., Breivik, K., Arefjord, K., Dalsbo, A.S., Jentoft, M.B.,
Hansen, A.L., Waage, L., 2013. Psychometric properties of the Norwegian version of
the Childhood Trauma Questionnaire in high-risk groups. Scand. J. Psychol. 54,
286–291.
Erdodi, L.A., Kirsch, N.L., Sabelli, A.G., Abeare, C.A., 2018. The Grooved Pegboard Test as
a validity indicator—a study on psychogenic interference as a confound in perfor-
mance validity research. Psychol Inj Law 11, 307–324.
Fisher, H., Craig, T.K., Fearon, P., Morgan, K., Dazzan, P., Lappin, J., Hutchinson, G.,
Doody, G.A., Jones, P.B., McGuffin, P., Murray, R.M., Leff, J., Morgan, C., 2011.
Reliability and comparability of psychosis patients' retrospective reports of childhood
abuse. Schizophr. Bull. 37, 546–553.
Gold, J.M., Randolph, C., Carpenter, C.J., Goldberg, T.E., Weinberger, D.R., 1992. The
performance of patients with schizophrenia on the wechsler memory scale-revised.
Clin. Neuropsychol. 6, 367–373.
Heaton, R.K., 1981. Wisconsin Card Sorting Test Manual. Psychological assessment re-
sources, Inc, Odessa, FL.
Johnsen, E., Jorgensen, H.A., Kroken, R.A., Loberg, E.M., 2013. Neurocognitive effec-
tiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, ran-
domized trial. Eur Psychiatry 28, 174–184.
Kahn, R.S., Keefe, R.S., 2013. Schizophrenia is a cognitive illness: time for a change in
N. Mørkved, et al. Schizophrenia Research: Cognition 21 (2020) 100179
7
focus. Jama Psychiat 70, 1107–1112.
Kay, S.R., Fiszbein, A., Opfer, L.A., 1987. The Positive and Negative Syndrome Scale
(PANSS) for schizophrenia. Schizophr. Bull. 13, 261–276.
Kessler, R.C., McLaughlin, K.A., Green, J.G., Gruber, M.J., Sampson, N.A., Zaslavsky,
A.M., Aguilar-Gaxiola, S., Alhamzawi, A.O., Alonso, J., Angermeyer, M., Benjet, C.,
Bromet, E., Chatterji, S., de Girolamo, G., Demyttenaere, K., Fayyad, J., Florescu, S.,
Gal, G., Gureje, O., Haro, J.M., Hu, C.Y., Karam, E.G., Kawakami, N., Lee, S., Lepine,
J.P., Ormel, J., Posada-Villa, J., Sagar, R., Tsang, A., Ustun, T.B., Vassilev, S., Viana,
M.C., Williams, D.R., 2010. Childhood adversities and adult psychopathology in the
WHO World Mental Health Surveys. Brit J Psychiat 197, 378–385.
Kopp, B., Lange, F., Steinke, A., 2019. The reliability of the Wisconsin Card Sorting Test in
clinical practice. Assessment 1–16 1073191119866257.
Lewis, R., Rennick, P.M., 1979. Manual for the Repeatable Cognitive-Perceptual-Motor
Battery. Axon, Grosse Point, MI.
Li, X.B., Bo, Q.J., Zhang, G.P., Zheng, W., Wang, Z.M., Li, A.N., Tian, Q., Liu, J.T., Tang,
Y.L., Wang, C.Y., 2017. Effect of childhood trauma on cognitive functions in a sample
of Chinese patients with schizophrenia. Compr. Psychiatry 76, 147–152.
Løberg, E.M., Helle, S., Nygård, M., Berle, J.O., Kroken, R.A., Johnsen, E., 2014. The
Cannabis pathway to non-affective psychosis may reflect less neurobiological vul-
nerability. Front Psychiatry 5, 159.
McGrath, J.J., McLaughlin, K.A., Saha, S., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J.,
Bruffaerts, R., de Girolamo, G., de Jonge, P., Esan, O., Florescu, S., Gureje, O., Haro,
J.M., Hu, C., Karam, E.G., Kovess-Masfety, V., Lee, S., Lepine, J.P., Lim, C.C.W.,
Medina-Mora, M.E., Mneimneh, Z., Pennell, B.E., Piazza, M., Posada-Villa, J.,
Sampson, N., Viana, M.C., Xavier, M., Bromet, E.J., Kendler, K.S., Kessler, R.C.,
Survey, W.W.M.H., 2017. The association between childhood adversities and sub-
sequent first onset of psychotic experiences: a cross-national analysis of 23 998 re-
spondents from 17 countries. Psychol. Med. 47, 1230–1245.
Mehmetoglu, M., Jakobsen, T.G., 2017. Applied Statistics Using Stata. A Guide for the
Social Sciences. Sage, UK.
Miller, E., 1990. California Computerized Assessment Package. Norland Software, Los
Angeles.
Molina, V., Alvarez-Astorga, A., Lubeiro, A., Ortega, D., Jimenez, M., Del Valle, P.,
Marques, P., de Luis-Garcia, R., 2018. Early neglect associated to prefrontal structural
disconnectivity in schizophrenia. Schizophr. Res. 192, 487–488.
Mørkved, N., Endsjø, M., Winje, D., Johnsen, E., Dovran, A., Arefjord, K., Kroken, R.A.,
Helle, S., Anda-Ågotnes, L.G., Rettenbacher, M.A., Huber, N., Løberg, E.M., 2017.
Childhood trauma in schizophrenia spectrum disorder as compared to other mental
health disorders. Psychosis 9, 48–56.
Mørkved, N., Winje, D., Dovran, A., Arefjord, K., Johnsen, E., Kroken, R.A., Anda-
Ågotnes, L.G., Thimm, J.C., Sinkeviciute, I., Rettenbacher, M., Løberg, E.M., 2018.
Childhood trauma in schizophrenia spectrum disorders as compared to substance
abuse disorders. Psychiatry Res. 261, 481–487.
Pechtel, P., Pizzagalli, D.A., 2011. Effects of early life stress on cognitive and affective
function: an integrated review of human literature. Psychopharmacology 214, 55–70.
Quide, Y., O'Reilly, N., Rowland, J.E., Carr, V.J., Elzinga, B.M., Green, M.J., 2016. Effects
of childhood trauma on working memory in affective and non-affective psychotic
disorders. Brain Imaging and Behav 11, 722–735.
Reitan, R.M., 1986. Trail Making Test: Manual for Administration and Scoring. Reitan
Neuropsychology Laboratory.
Ruby, E., Rothman, K., Corcoran, C., Goetz, R.R., Malaspina, D., 2017. Influence of early
trauma on features of schizophrenia. Early Interv Psychia 11, 322–333.
Schalinski, I., Teicher, M.H., Nischk, D., Hinderer, E., Muller, O., Rockstroh, B., 2016.
Type and timing of adverse childhood experiences differentially affect severity of
PTSD, dissociative and depressive symptoms in adult inpatients. BMC Psychiatry 16,
295.
Schalinski, I., Breinlinger, S., Hirt, V., Teicher, M.H., Odenwald, M., Rockstroh, B., 2019a.
Environmental adversities and psychotic symptoms: the impact of timing of trauma,
abuse, and neglect. Schizophr. Res. 205, 4–9.
Schalinski, I., Teicher, M.H., Rockstroh, B., 2019b. Early neglect is a key determinant of
adult hair cortisol concentration and is associated with increased vulnerability to
trauma in a transdiagnostic sample. Psychoneuroendocrinology 108, 35–42.
Shannon, C., Douse, K., McCusker, C., Feeney, L., Barrett, S., Mulholland, C., 2011. The
association between childhood trauma and memory functioning in schizophrenia.
Schizophr. Bull. 37, 531–537.
Shin, M.-S., Park, S.-Y., Park, S.-R., Seol, S.-H., Kwon, J.S., 2006. Clinical and empirical
applications of the Rey–Osterrieth complex figure test. Nat. Protoc. 1, 892–899.
Shunk, A.W., Davis, A.S., Dean, R.S., 2006. TEST REVIEW: Dean C. Delis, Edith Kaplan &
Joel H. Kramer, Delis Kaplan Executive Function System (D-KEFS), The Psychological
Corporation, San Antonio, TX, 2001. $415.00 (complete kit). Appl. Neuropsychol. 13
275-27.
Silva, M.A., 2008. Development of the WAIS-III: a brief overview, history, and descrip-
tion. Grad J Couns Psychol 1, 11.
Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., 1992. The structured clinical in-
terview for Dsm-III-R (Scid). 1. History, rationale, and description. Arch. Gen.
Psychiatry 49, 624–629.
Stroop, J.R., 1935. Studies of interference in serial-verbal reaction. J. Exp. Psychol. 18,
643–663.
Teicher, M.H., Samson, J.A., 2013. Childhood maltreatment and psychopathology: a case
for ecophenotypic variants as clinically and neurobiologically distinct subtypes. Am.
J. Psychiatry 170, 1114–1133.
Ucok, A., Kaya, H., Ugurpala, C., Cikrikcili, U., Ergul, C., Yokusoglu, C., Bulbul, O., Direk,
N., 2015. History of childhood physical trauma is related to cognitive decline in in-
dividuals with ultra-high risk for psychosis. Schizophr. Res. 169, 199–203.
van Os, J., Marsman, A., van Dam, D., Simons, C.J., 2017. Evidence that the impact of
childhood trauma on IQ is substantial in controls, moderate in siblings, and absent in
patients with psychotic disorder. Schizophr. Bull. 43, 316–324.
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., Read, J.,
van Os, J., Bentall, R.P., 2012. Childhood adversities increase the risk of psychosis: a
meta-analysis of patient-control, prospective- and cross-sectional cohort studies.
Schizophr. Bull. 38, 661–671.
Wechsler, D., 1997. Wechsler Memory Scale (WMS-III). Psychological corporation, San
Antonio, TX.
Wells, R., Jacomb, I., Swaminathan, V., Sundram, S., Weinberg, D., Bruggemann, J.,
Cropley, V., Lenroot, R.K., Pereira, A.M., Zalesky, A., Bousman, C., Pantelis, C.,
Weickert, C.S., Weickert, T.W., 2019. The impact of childhood adversity on cognitive
development in schizophrenia. Schizophr. Bull. 46 (1), 140–153.
WHO, 1992. ICD-10 Classifications of Mental and Behavioural Disorder: Clinical
Descriptions and Diagnostic Guidelines. World Health Organization, Geneva.
Woods, S.P., Delis, D.C., Scott, J.C., Kramer, J.H., Holdnack, J.A., 2006. The California
Verbal Learning Test–second edition: test-retest reliability, practice effects, and re-
liable change indices for the standard and alternate forms. Arch. Clin. Neuropsychol.
21, 413–420.
N. Mørkved, et al. Schizophrenia Research: Cognition 21 (2020) 100179
8
